rosiglitazone has been researched along with Day Blindness in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colucciello, M | 1 |
1 other study(ies) available for rosiglitazone and Day Blindness
| Article | Year |
|---|---|
Vision loss due to macular edema induced by rosiglitazone treatment of diabetes mellitus.
Topics: Diabetes Mellitus, Type 2; Fluorescein Angiography; Humans; Hypoglycemic Agents; Macular Edema; Male; Middle Aged; Rosiglitazone; Thiazolidinediones; Vision Disorders | 2005 |